Riaz Alvi

530 total citations
15 papers, 370 citations indexed

About

Riaz Alvi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Riaz Alvi has authored 15 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Riaz Alvi's work include Colorectal Cancer Screening and Detection (4 papers), Economic and Financial Impacts of Cancer (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Riaz Alvi is often cited by papers focused on Colorectal Cancer Screening and Detection (4 papers), Economic and Financial Impacts of Cancer (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Riaz Alvi collaborates with scholars based in Canada and United States. Riaz Alvi's co-authors include Shahid Ahmed, Kamal Haider, Sunil Kumar Yadav, Amer Sami, Jon Tonita, David R. Popkin, Rabia Shahid, Daygen L. Finch, Imran Ahmad and Anne Leis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Riaz Alvi

14 papers receiving 362 citations

Peers

Countries citing papers authored by Riaz Alvi

Since Specialization

Citations

This map shows the geographic impact of Riaz Alvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riaz Alvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riaz Alvi more than expected).

Fields of papers citing papers by Riaz Alvi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riaz Alvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riaz Alvi. The network helps show where Riaz Alvi may publish in the future.

Co-authorship network of co-authors of Riaz Alvi

This figure shows the co-authorship network connecting the top 25 collaborators of Riaz Alvi. A scholar is included among the top collaborators of Riaz Alvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riaz Alvi. Riaz Alvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Harnessing the power of data linkage to enrich the cancer research ecosystem in Canada. 2022 ·International Journal for Population Data Science ·Robin Urquhart, Philip Awadalla, Parveen Bhatti, Trevor Dummer, Simon Gravel, Jennifer E. Vena, Riaz Alvi, Philippe Broët, Cynthia Kendell, Victoria A. Kirsh, Guillaume Lettre, Kimberly Skead, Grace Shen‐Tu, Ellen Sweeney, Donna Turner	1
2	Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces 2021 ·MDM Policy & Practice ·Reka Pataky, Jaclyn Beca, David Tran, Wei Fang Dai, (unknown), Wanrudee Isaranuwatchai, Stuart Peacock, Riaz Alvi, Winson Y. Cheung, Craig C. Earle, Scott Gavura, Kelvin Chan	9
3	Cancer drug expenditure in British Columbia and Saskatchewan: a trend analysis 2018 ·CMAJ Open ·Reka Pataky, (unknown), (unknown), Riaz Alvi, (unknown), Dean A. Regier, Stuart Peacock	4
4	Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers 2016 ·Breast Cancer Research ·Alison K Ward, Paul Mellor, (unknown), (unknown), (unknown), Frederick S. Vizeacoumar, (unknown), (unknown), Riaz Alvi, Anurag Saxena, Franco J. Vizeacoumar, Svein A. Carlsen, Deborah H. Anderson	49
5	Surgical management of the primary tumor in stage IV colorectal cancer: A validation study. 2015 ·Journal of Clinical Oncology ·Shahid Ahmed, Punam Pahwa, Selliah Kanthan, Anthony Fields, Duc Le, Kamal Haider, Bruce Reeder, (unknown), Riaz Alvi, Nayyer Iqbal, Tahir Abbas, (unknown), (unknown), Sunil Kumar Yadav, Amer Sami, Anne Leis	0
6	Time to Adjuvant Therapy and Other Variables in Localized Gastric and Gastroesophageal Junction (GEJ) Cancer (IJGC-D-13-00162) 2014 ·Journal of Gastrointestinal Cancer ·Shahid Ahmed, Nayyer Iqbal, Sunil Kumar Yadav, (unknown), (unknown), Riaz Alvi, (unknown), Kamal Haider	12
7	Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: Results from a large population‐based cohort study 2013 ·Cancer ·Shahid Ahmed, Anne Leis, Anthony Fields, (unknown), Kamal Haider, Riaz Alvi, Bruce Reeder, Punam Pahwa	57
8	Low‐serum GTA‐446 anti‐inflammatory fatty acid levels as a new risk factor for colon cancer 2012 ·International Journal of Cancer ·Shawn Ritchie, Jon Tonita, Riaz Alvi, Denis C. Lehotay, (unknown), (unknown), James D. McHattie, Dayan B. Goodenowe	33
9	Abstract 4515: Low serum levels of a novel anti-inflammatory fatty acid as a new risk factor for colorectal cancer 2012 ·Cancer Research ·Shawn Ritchie, Jon Tonita, Riaz Alvi, Denis C. Lehotay, (unknown), James D. McHattie, Dayan B. Goodenowe	5
10	Early Discontinuation but Not the Timing of Adjuvant Therapy Affects Survival of Patients With High-Risk Colorectal Cancer: A Population-Based Study 2010 ·Diseases of the Colon & Rectum ·Shahid Ahmed, Imran Ahmad, Tong Zhu, (unknown), (unknown), Amer Sami, Sunil Kumar Yadav, Riaz Alvi, Kamal Haider	41
11	Comparison of Treatment Received Versus Long-Standing Guidelines for Stage III Colon and Stage II/III Rectal Cancer Patients Diagnosed in Alberta, Saskatchewan, and Manitoba in 2004 2009 ·Clinical Colorectal Cancer ·Marilyn Cree, Jon Tonita, Donna Turner, Zoann Nugent, Riaz Alvi, (unknown), Charlotte King, Marcy Winget	31
12	Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT) 2008 ·Radiation Oncology ·Kurian Joseph, Riaz Alvi, David Skarsgard, Jon Tonita, Nadeem Pervez, Cormac Small, Patricia Tai	11
13	Across-province standardization and comparative analysis of time-to-care intervals for cancer 2007 ·BMC Cancer ·Marcy Winget, Donna Turner, Jon Tonita, Charlotte King, Zoann Nugent, Riaz Alvi, (unknown)	9
14	Extrapulmonary small cell cancer 2006 ·Cancer ·Kamal Haider, Rabia Shahid, Daygen L. Finch, Amer Sami, Imran Ahmad, Sunil Kumar Yadav, Riaz Alvi, David R. Popkin, Shahid Ahmed	101
15	Women with multiple primary breast cancers diagnosed within a five year period, 1994?1998 2005 ·Breast Cancer Research and Treatment ·Holly L. Howe, Rachel Weinstein, Riaz Alvi, Betsy Kohler, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact